HTSF Sequencer Moving and Holiday Closure Information

The HTSF sequencers are re-locating to Genome Sciences Building.
We will  be closing down our HiSeq and NovaSeq sequencers on January 15, 2020.  Final data sets will be delivered by 1/17/20. We hope to have the sequencers validated and running by February 3rd
We will continue accepting samples, making libraries and running the machines until 12/17/19. Final 2019 will be data delver 12/20/19.
We will resume all operations 1/6/2020. Sample submission, library preparation and MiSeqs will continue uninterrupted.

12/20/19: HTSF closes for December break
1/6/2020: HSTF reopens with full services
1/15/2020: HISEQ and NOVASEQ are shut down, Miseq and other service continue
2/3/2020: HTSF offers full services again

Welcome to the High Throughput Genomic Sequencing Facility


History and Mission

The HTSF was established in 2008 with funds from the University Cancer Research Fund (UCRF) and the Lineberger Comprehensive Cancer Center (LCCC) and is managed by the UNC School of Medicine.

Our primary goal is to apply the tools of high throughput sequencing technology and experience to enrich medicine and basic biological research at The University of North Carolina. High-throughput sequencing is an extremely fast developing technology that is used to extract genetic and genomic data from a broad spectrum of biological materials. This information is not only be used to help identify the causes of complex diseases such as cancer, diabetes and cardiovascular disease and demonstrate the underlying bases for multiple types of infectious diseases.  It can be also used to analyze the complexities of diverse biological systems. Our goal is to support UNC researchers, students, and their collaborators in their work with our state-of-the-art technology to make medical and scientific breakthroughs happen.

We support all commercially available high throughput sequencing platforms and regularly work with researchers to develop and implement novel cutting edge applications with these platforms. We frequently work directly with the developers of new systems as an early access customer to give them useful feedback and to give our researchers the earliest possible access to novel new technologies.